Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Gerald F. Watts
Based on 12 articles published since 2008
||||
Expertise Level
The expertise of Gerald F. Watts ranks in the
  • Top 0.17%
  • ... of 28,550 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Watts, Gerald F   ·   Watts, G F   ·   Watts, G   ·   Watts, Gerald F
Work Locations
Details
Most likely:    University of Western Australia      
2018
  • School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Services, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia. Electronic address: · School of Public Health, Curtin University, Bentley, Western Australia, Australia. · Pubmed 29887280
2017
  • Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: · Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia. · University of Iowa, Iowa City, Iowa. · Biostatistics and Programming, Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 27793396
  • Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.). · Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.). · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.). · Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.). · College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.). · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Pubmed 28877913
  • Princess Margaret Hospital for Children, Perth, WA, Australia. · University of Western Australia, Perth, WA, Australia · Pubmed 28150923
2016
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands · Duke University Medical Center, Durham, NC. · Westside Medical Associates of Los Angeles Cedars-Sinai Heart Institute, Beverly Hills, CA. · Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, Zaragoza, Spain. · ECOGENE-21 Clinical and Translational Research Center and Department of Medicine, Université de Montréal, Chicoutimi, Quebec, Canada. · Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Sanofi, Clinical Development, R&D, Montpellier, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals Inc, Tarrytown, NY. · Lipid Clinic, Point Médical, Dijon, France. · Pubmed 27625344
  • Mehiläinen Airport Health Center, Vantaa, Finland. · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia. · Wihuri Research Institute, Helsinki, Finland. · Pubmed 27678448
2014
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Wesley Medical Centre, Auchenflower, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Hospital Universitario Miguel Servet, Zaragoza, Spain. · Cardiometabolic Disorders Department, Icahn School of Medicine at Mount Sinai, New York, New York. · Lipid Disorders Clinic, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Hopital Pitie-Salpetriere, Paris, France. · Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Amgen, Thousand Oaks, California. · Cardiovascular Medicine Department, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24694531
  • Department of Nutrition and Foodborne Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, China; Discipline of Medicine, University of Adelaide, South Australia, Australia. Electronic address: · Department of Nutrition and Foodborne Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, China. · Department of Epidemiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China. · Discipline of Medicine, University of Adelaide, South Australia, Australia. · Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University, China. · Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia. · Pubmed 24801084
2014
  • School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 24506448
2009
  • University of Western Australia, Royal Perth Hospital, Lipid Disorders Clinic, Department of Internal Medicine, Australia. · Pubmed 19954271
Possible:    Miscellaneous cities in Iran      
2013
  • Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. · Pubmed 23932550
Possible:    Monash University      
2012
  • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Pubmed 23141810
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Gerald F. Watts about Hypercholesterolemia:

  • Squaring up the health economics of PCSK9 monoclonal antibodies 'down under'. 2018
  • Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program). 2017
  • Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up. 2017
  • Child-Parent Familial Hypercholesterolemia Screening in Primary Care. 2017
  • Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study. 2016
  • Rescue therapy with PCSK9 inhibitors for patients with delayed diagnosis of heterozygous familial hypercholesterolemia: Redressing the balance of missed opportunities. 2016
  • Critical review of non-statin treatments for dyslipoproteinemia. 2014
  • Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. 2014
  • Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. 2014
  • New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. 2013
Show List of Full Article Records
Google Searches

Learn more about Gerald F. Watts using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Western Australia
Miscellaneous cities in Iran
Monash University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Western Australia
2018
  • School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Services, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia. Electronic address: · School of Public Health, Curtin University, Bentley, Western Australia, Australia. · Pubmed 29887280
2017
  • Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: · Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia. · University of Iowa, Iowa City, Iowa. · Biostatistics and Programming, Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 27793396
  • Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.). · Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.). · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.). · Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.). · College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.). · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Pubmed 28877913
  • Princess Margaret Hospital for Children, Perth, WA, Australia. · University of Western Australia, Perth, WA, Australia · Pubmed 28150923
2016
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands · Duke University Medical Center, Durham, NC. · Westside Medical Associates of Los Angeles Cedars-Sinai Heart Institute, Beverly Hills, CA. · Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, Zaragoza, Spain. · ECOGENE-21 Clinical and Translational Research Center and Department of Medicine, Université de Montréal, Chicoutimi, Quebec, Canada. · Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Sanofi, Clinical Development, R&D, Montpellier, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals Inc, Tarrytown, NY. · Lipid Clinic, Point Médical, Dijon, France. · Pubmed 27625344
  • Mehiläinen Airport Health Center, Vantaa, Finland. · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia. · Wihuri Research Institute, Helsinki, Finland. · Pubmed 27678448
2014
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: · Wesley Medical Centre, Auchenflower, Australia. · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia. · Hospital Universitario Miguel Servet, Zaragoza, Spain. · Cardiometabolic Disorders Department, Icahn School of Medicine at Mount Sinai, New York, New York. · Lipid Disorders Clinic, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Hopital Pitie-Salpetriere, Paris, France. · Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, Ohio. · Amgen, Thousand Oaks, California. · Cardiovascular Medicine Department, Cleveland Clinic, Cleveland, Ohio. · Pubmed 24694531
  • Department of Nutrition and Foodborne Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, China; Discipline of Medicine, University of Adelaide, South Australia, Australia. Electronic address: · Department of Nutrition and Foodborne Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, China. · Department of Epidemiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China. · Discipline of Medicine, University of Adelaide, South Australia, Australia. · Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University, China. · Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia. · Pubmed 24801084
2014
  • School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 24506448
2009
  • University of Western Australia, Royal Perth Hospital, Lipid Disorders Clinic, Department of Internal Medicine, Australia. · Pubmed 19954271
Miscellaneous cities in Iran
2013
  • Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. · Pubmed 23932550
Monash University
2012
  • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Pubmed 23141810
Yearly article counts 13203110010
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.